Assessment of the Impact of Numerous Medicinal Plants on Trichomonas Vaginalis: A Review

Assessment of the Impact of Numerous Medicinal Plants on Trichomonas Vaginalis: A Review

Sarita Gaikwad1, Swarnlata Saraf2

University Institute of Pharmacy, Pandit Ravishankar Shukla University, Raipur, Chhattisgarh 492001-India

Corresponding author*

Swarnlata Saraf

University Institute of Pharmacy,

Pandit Ravishankar Shukla University, Raipur, Chhattisgarh 492001-India.

Abstract

The most common non-viral sexually transmitted illness in the world, trichomoniasis, is caused by the etiological agent Trichomonas vaginalis. Trichomoniasis is a prevalent, global health issue that is becoming worse. While infections in males are typically asymptomatic, infections in the female genital tract can result in a variety of symptoms, including vaginitis and cervicitis. This condition has historically been underdiagnosed and under researched due to its generally mild symptoms and the absence of any evidence for any major repercussions. The attempts to identify and treat patients harbouring this parasite have risen, however, in light of mounting evidence that T. vaginalis infection is linked to various disease states with high morbidity in both men and women. Recent research has highlighted the complex interactions between the parasite and host, commensal microbiota, and associated symbionts. The pathophysiology of trichomoniasis is produced by damage to the host epithelia, mediated by a multitude of events during infection. The number of accessible diagnostic alternatives has increased as a result of the commercial introduction of several nucleic acid amplification tests (NAATs). Immunoassay based Point of Care testing is currently available, and a recent initial evaluation of a NAAT Point of Care system has given promising results, which would enable testing and treatment in a single visit.

Keywords: Clinical, diagnostics, point of care, trichomoniasis, trichomonas vaginalis, parasitic infection